Related references
Note: Only part of the references are listed.Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study
Nghi B. Ha et al.
CANCER CAUSES & CONTROL (2012)
Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively
Masahiro Kobayashi et al.
HEPATOLOGY RESEARCH (2011)
Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma
Peng Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
David M. Levi et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Factors Associated with Progression to Hepatocellular Carcinoma and to Death from Liver Complications in Patients with HBsAg-Positive Cirrhosis
Myron John Tong et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
Ryosuke Tateishi et al.
HEPATOLOGY INTERNATIONAL (2008)
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis
N. Snowberger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Hepatitis status, Child-Pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma
TCW Reichman et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Clinical characteristics and prognosis of hepatocellular carcinoma - Analaysis based on serum alpha-fetoprotein levels
P Tangkijvanich et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Share Paper
